| Sandoz Pharmaceuticals AG - Carbidopa/Levodopa Sandoz CR 50/200, Retardtabletten |
| 57275 | | 02 | | Carbidopa/Levodopa Sandoz CR 50/200 | | Retardtabletten | | N04BA02 | | Levodopa and Decarboxylase Inhibitor | | 29.06.2007 | | |
|
| Composition |
| carbidopum 50.00 mg ut carbidopum monohydricum, levodopum 200.00 mg, hypromellosum, silica colloidalis anhydrica, acidum fumaricum, natrii stearylis fumaras corresp. natrium 0.47 mg, E 104, Überzug: hypromellosum, macrogolum 6000, E 172 (flavum), E 172 (rubrum), E 171, pro compresso obducto. |
| Packungsbestandteile |
| Delayed release tablets | | | | | Active Agent | Dose |
|---|
| Carbidopa | 50 mg | | Levodopa | 200 mg |
| | BAG: Active Agent | Dose |
|---|
| Carbidopa | 50 mg | | Levodopa | 200 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| (Flavum) | | | | (Rubrum) | | | | Acidum Fumaricum | | | | E 104 | | color. | | E 171 | | color. | | E 172 | | color. | | Hypromellosum | | Überzug | | Macrogol | 6000 | | | Natrii Stearylis Fumaras | | | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | |
| |
|
| Teilbarkeit |
| | Nein | | | | kA | | | | Nein | | | | -- | | | | Nicht zerkauen oder zermörsern => Retardprinzip wird zerstört, Überdosierungen sind möglich [2] | | | | | [2] Firmeninformation |
|
|
